Phase I / Dose Expansion Study of Enadenotucirev in Ovarian Cancer Patients

Clinical trial NCT02028117 · COMPLETED

Trial details

NCT number: NCT02028117
Sponsor: Akamis Bio
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Platinum Resistant Ovarian Cancer

Start date: 2014-06-01
Primary completion: 2019-11-19
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.